Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
GIP stimulieren, was zu einer Regulation des Blutzuckerspiegels und einer Verringerung des Hungergefhls fhren kann
This could expand the choices for patients who prefer not to use needles or who struggle with swallowing pills
Currently, RM-718 is being tested in a four-part phase I clinical trial in participants with general obesity, HO, and Prader-Willi Syndrome (NCT06239116)
In the general population, xerostomia prevalence ranges from 5.5% to 46%, depending on the population studied and the definition used
Assumptions of normality (ShapiroWilk test) and homogeneity of variance (Levenes test) were verified
US$ 24.76
US$ 20.43
US$ 20.67
US$ 25.55
US$ 27.58
